Therapeutic Plasma Exchange Market Intelligence Report - Global Forecast to 2027

Therapeutic Plasma Exchange Market Intelligence Report - Global Forecast to 2027

The Global Therapeutic Plasma Exchange Market is projected to reach USD 1,159.52 million by 2027 from USD 636.56 million in 2021, at a CAGR 10.51% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Therapeutic Plasma Exchange Market size was estimated at USD 252.31 million in 2021 and expected to reach USD 281.63 million in 2022, at a CAGR 10.51% to reach USD 459.66 million by 2027.
• The Asia-Pacific Therapeutic Plasma Exchange Market size was estimated at USD 144.39 million in 2021 and expected to reach USD 164.69 million in 2022, at a CAGR 11.29% to reach USD 274.37 million by 2027.
• The Europe, Middle East & Africa Therapeutic Plasma Exchange Market size was estimated at USD 239.84 million in 2021 and expected to reach USD 264.14 million in 2022, at a CAGR 10.02% to reach USD 425.48 million by 2027.

Market Segmentation & Coverage:

The report on therapeutic plasma exchange identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the therapeutic plasma exchange to forecast the revenues and analyze the trends in each of the following sub-markets:

Technology:

• Centrifugation
• Membrane Separation

Indication:

• Hematologic Disorders
  • Atypical Hemolytic Uremic Syndrome
  • Hyperviscosity Syndrome
  • Severe/Symptomatic Cryoglobulinemia
  • Thrombotic Thrombocytopenic Purpura
• Metabolic Disorders
• Neurological Disorders
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Guillain-Barré Syndrome
  • Multiple Sclerosis
  • Myasthenia Gravis
  • PANDAS
• Renal Disorders
  • Antibody-mediated Renal Transplant Rejection
  • Goodpasture Syndrome
  • Wegener's Granulomatosis

Product:

• Consumables
• Devices

End-user:

• Blood Collection Centers & Blood Component Providers
• Hospitals & Transfusion Centers

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • Alaska
    • California
    • Florida
    • Illinois
    • Massachusetts
    • Michigan
    • Montana
    • Nevada
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Asahi Kasei Medical Co., Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Cerus Corporation
• Fresenius SE & Co. KGaA
• Grifols, S.A.
• Haemonetics Corporation
• Haier Biomedical
• HemaCare
• Infomed SA
• Kaneka Corporation
• Kawasumi Laboratories, Inc.
• Medica S.p.A.
• Medicap Clinic GmbH
• MEISE Medizintechnik GmbH
• Miltenyi Biotec
• Nikkiso Co., Ltd.
• Pall Corporation
• Terumo BCT, Inc.